Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-22T08:25:33.976Z Has data issue: false hasContentIssue false
  • English
  • Français

Cytochromes and Psychotropic Drug Interactions

Published online by Cambridge University Press:  02 January 2018

David Taylor  and
Malcolm Lader
David Taylor
Affiliation:
Maudsley Hospital, London SE5 8AF
Malcolm Lader*
Affiliation:
Maudsley Hospital, London SE5 8AF
*
Professor M. Lader, Maudsley Hospital, Denmark Hill, London SE5 8AF. Fax: 0171 919 2171
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials
Information
The British Journal of Psychiatry , Volume 168 , Issue 5 , May 1996 , pp. 529 - 532
Copyright
Copyright © 1996 The Royal College of Psychiatrists 

References

Alderman, J., Greenblatt, D. J., Allison, J., et al (1994) Desipramine pharmacokinetics with the serotonin reuptake inhibitors, paroxetine or sertraline. Data on File. Sandwich, Kent: Pfizer.Google Scholar
Barros, J. & Asnis, G. (1993) An interaction of sertraline and desipramine. American Journal of Psychiatry, 150, 1751.Google ScholarPubMed
Brøsen, K., Skjelbo, E., Rasmussen, B. B., et al (1993) Fluvoxamine is a potent inhibitor of cytochrome P450–1A2. Biochemical Pharmacology, 45, 1211–1214.Google Scholar
Centorrino, F., Baldessarini, R.J., Kando, J., et al (1994) Serum concentrations of clozapine and its major metabolites: effects of co-treatment with fluoxetine or valproate. American Journal of Psychiatry, 151, 123–125.Google Scholar
Cholerton, S., Daly, A. K. & Idle, J. R. (1992) The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends in Pharmacological Science, 13, 434–439.CrossRefGoogle ScholarPubMed
Crewe, H. K., Lennard, M. S., Tucker, G. T., et al (1992) The effect of selective serotonin re-uptake inhibitors on cytochrome P450 2D6 (CYP2D6) activity in human liver microsomes. British Journal of Clinical Pharmacology, 34, 262–265.Google Scholar
Fischer, V., Vogels, B., Maurer, G., et al (1992) The antipsychotic clozapine is metabolised by the polymorphic human microsomal and recombinant cytochrome P450 2D6. Journal of Pharmacology and Experimental Therapeutics, 260, 1355–1360.Google Scholar
Gascon, M.-P. & Dayer, P. (1991) In vitro forecasting of drugs which may interfere with the biotransformation of midazolam. European Journal of Clinical Pharmacology, 41, 573–578.Google Scholar
Gorski, J. C., Hall, S. D., Jones, D. R., et al (1994) Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP 3A) subfamily. Biochemical Pharmacology, 47, 1643–1653.Google Scholar
Gram, L. F., Hansen, M. G. J., Sindrup, S. H., et al (1993) Citalopram: Interaction studies with levomepromazine, imipramine, and lithium. Therapeutic Drug Monitoring, 15, 18–24.Google Scholar
Guengerich, F. P. (1992) Human cytochrome P-450 enzymes. Life Sciences, 50, 1471–1478.CrossRefGoogle ScholarPubMed
Hahn, S. M. & Griffin, J. H. (1991) Comment: fluoxetine adverse effects of drug interactions. DICP – Annals of Pharmacotherapy, 25, 1273–1274.Google ScholarPubMed
Hartter, S. H., Wetzel, H., Hammes, E., et al (1993) Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients. Psychopharmacology, 110, 302–308.CrossRefGoogle ScholarPubMed
Horton, R. C. & Bonser, R. S. (1995) Interaction between cyclosporin and fluoxetine. British Medical Journal, 311, 422.CrossRefGoogle ScholarPubMed
Ketai, R. (1993) Interaction between fluoxetine and neuroleptics. American Journal of Psychiatry, 150, 836–837.Google Scholar
Kronbach, T., Mathys, D., Umeno, M., et al (1989) Oxidation of midazolam and triazolam by human liver cytochrome P450 IIIA4. Molecular Pharmacology, 36, 89–96.Google Scholar
Lasher, T. A., Fleishaker, J. C., Steenwijk, R. C., et al (1991) Pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine. Psychopharmacology, 104, 323–327.CrossRefGoogle ScholarPubMed
Marchiando, R. J. & Cook, M. D. (1995) Probable terfenadine-fluoxetine-associated cardiac toxicity. Annals of Pharmacotherapy, 29, 937–938.CrossRefGoogle ScholarPubMed
Maskall, D. D. & Lam, R. W. (1993) Increased plasma concentration of imipramine following augmentation with fluvoxamine. American Journal of Psychiatry, 150, 1566.Google ScholarPubMed
Murray, M. (1992) P450 enzymes: inhibition mechanisms, genetic regulation and effects of liver disease. Clinical Pharmacokinetics, 23, 132–146.Google Scholar
Preskorn, S. H., Beber, J. H., Faul, J. C., et al (1990) Serious adverse effects of combining fluoxetine and tricyclic antidepressants. American Journal of Psychiatry, 147, 532.Google ScholarPubMed
Preskorn, S. H., Alderman, J., Chung, M., et al (1994) Pharmacokinetics of desipramine co-administered with sertraline or fluoxetine. Journal of Clinical Psychopharmacology, 14, 90–98.Google Scholar
Preskorn, S. H., & Magnus, R. D. (1994) Inhibition of hepatic P-450 isoenzymes by selective serotonin reuptake inhibitors: In vitro and in vivo findings and their implications for patient care. Psychopharmacology Bulletin, 30, 251–259.Google ScholarPubMed
Rasmussen, B. B., Maenpaa, J., Pelkonen, O., et al (1995) Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine. British Journal of Clinical Pharmacology, 39, 151–159.Google Scholar
Simpson, G. M. & Cooper, T. A. (1978) Clozapine plasma levels and convulsions. American Journal of Psychiatry, 135, 99–100.Google Scholar
Slaughter, R. L. & Edwards, D. J. (1995) Recent advances: The cytochrome P450 enzymes. Annals of Pharmacotherapy, 29, 619–624.Google Scholar
Thomson, A. H., McGovern, E. M., Bennie, P., et al (1992) Interaction between fluvoxamine and theophylline. Pharmaceutical Journal, 249, 137.Google Scholar
von Moltke, L. L., Greenblatt, D. J., Harmatz, J. S., et al (1993) Alprazolam metabolism in vitro: studies of human, monkey, mouse, and rat liver microsomes. Pharmacology, 47, 268–276.Google Scholar
von Moltke, L. L., Greenblatt, D. J., Harmatz, J. S., et al (1994) Cytochromes in psychopharmacology. Journal of Clinical Psychopharmacology, 14, 1–2.Google ScholarPubMed
Watkins, P. B. (1990) Role of cytochromes P450 in drug metabolism and hepatotoxicity. Seminars in Liver Disease, 10, 235–250.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.